Product
Verekitug
Aliases
Verekitug (UPB-101)
2 clinical trials
2 indications
Indication
AsthmaIndication
Chronic RhinosinusitisClinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)Status: Recruiting, Estimated PCD: 2026-02-19
Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)Status: Recruiting, Estimated PCD: 2025-03-01